![[TargetMol Star Molecule] - LCL161: Modulating Apoptosis via IAP Antagonism with Promising Anti-Cancer Applications](https://img03.71360.com/w3/pjq98x/20261015/0b5f51bafa8cf5de04de126128b31db1.png)
[TargetMol Star Molecule] - LCL161: Modulating Apoptosis via IAP Antagonism with Promising Anti-Cancer Applications
■ 1. Background LCL161 (T2080), CAS: 1005342-46-0 is a small-molecule SMAC mimetic that functions as a pan-IAP antagonist with oral activity, designed to disengage inhibitor of apoptosis proteins (IAPs) from...